T cell modulation in adaptive immune responses is key to anticipating and mitigating future viral threats
The adaptive immune system is a remarkable defense mechanism that enables the human body to recognize and mount targeted responses against specific pathogens. Central to this process are T cells – a type of white blood cell that play a pivotal role in orchestrating immune responses. Understanding and modulating T cell responses is crucial for harnessing the full potential of the adaptive immune system, providing valuable insights for preparing for and combating future viral threats.
T cell fundamentals
T cells are critical components of the adaptive immune system and are responsible for cell-mediated immunity. These cells possess specific receptors known as T cell receptors, which allow them to recognize and bind to antigens presented by infected or abnormal cells. The two primary types of T cells involved in adaptive immune responses are:
Modulation for future viral threats
T cell testing has been of interest to multiple companies and researchers because of its potential to provide a more accurate picture of immunity, given that T cell immune response often lasts longer than antibodies. T cell testing can help us respond to future viral threats, in areas such as:
Overall, T cell modulation in adaptive immune responses represents a frontier of research with the potential to shape the future of viral threat preparedness and management. By understanding and harnessing the power of T cells, scientists and healthcare professionals can develop more effective vaccines, antiviral therapies, and strategies to combat emerging viral threats. Advances in T cell research and immunomodulatory techniques will be pivotal in fostering a world better equipped to respond to and control viral outbreaks – ultimately safeguarding global health.
JW Yewdell, SM Haeryfar, “Understanding presentation of viral antigens to CD8+ T cells in vivo: the key to rational vaccine design,” Annu Rev Immunol, 23, 651 (2005). PMID: 15771583.
EJ Wherry, M Kurachi, “Molecular and cellular insights into T cell exhaustion. Nature Reviews Immunology,” Nat Rev Immunol, 15, 486 (2015). PMID: 26205583.
A Sette, S Crotty, “Adaptive immunity to SARS-CoV-2 and COVID-19,” Cell, 184, 861 (2021). PMID: 33497610.
A Grifoni et al., “Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals,” Cell, 181, 1489 (2020). PMID: 32473127.